Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04255589 |
| Consolidated Lead Sponsor | Chong Kun Dang Pharmaceutical |
| Therapeutic Condition Cohort | Rare Genetic, Women's Health, and Other |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 242 participants (ACTUAL) |
| Registered Start Date | 2020-01-06 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Chonnam National University Hospital | Gwangju, South Korea | Open Hospital Dossier -> |
| Seoul National University Bundang Hospital | Seongnam, South Korea | Open Hospital Dossier -> |
| Chung-Ang University Hospital | Seoul, South Korea | Open Hospital Dossier -> |
| Kangbuk Samsung Hospital | Seoul, South Korea | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.